From the Department of Imaging, Dana-Farber Cancer Institute.
Department of Radiology, Brigham and Women's Hospital and Harvard Medical School.
Clin Nucl Med. 2022 Mar 1;47(3):e281-e283. doi: 10.1097/RLU.0000000000003980.
A 67-year-old man with metastatic lung adenocarcinoma was initially treated with whole-brain radiotherapy for intracranial metastases, followed by chemotherapy and pembrolizumab. After completing 2 years of systemic therapy, the primary right lung lesion was biopsy-proven to have residual adenocarcinoma, which was then treated with radiation (6000 cGy in 15 fractions). Follow-up serial FDG PET/CT showed radiation fibrosis. Eighteen months after radiotherapy, the patient received 2 doses of an mRNA COVID-19 vaccine. FDG PET/CT performed 4 days following his second vaccine dose showed FDG-avid multistation lymphadenopathy and radiation recall pneumonitis, likely vaccination-induced and mimicking recurrent disease. This resolved spontaneously without therapy.
一位 67 岁男性患有转移性肺腺癌,最初接受全脑放疗治疗颅内转移,随后进行化疗和帕博利珠单抗治疗。完成 2 年的系统治疗后,对原发性右肺病变进行了活检,证实仍有残留的腺癌,随后进行了放射治疗(15 次分割,每次 6000 cGy)。后续连续 FDG PET/CT 显示放射性纤维化。放射治疗后 18 个月,患者接受了 2 剂 mRNA COVID-19 疫苗。第二剂疫苗接种后 4 天进行的 FDG PET/CT 显示 FDG 摄取的多部位淋巴结病和放射性回忆性肺炎,可能是疫苗诱导的,类似于复发性疾病。该患者未接受治疗即自行缓解。